Pacific Biosciences Of California (PACB) Price to FCF (2010 - 2026)

Pacific Biosciences Of California has reported Price to FCF for 17 years, with the latest figure at 14.06 in Q2 2026.

• On a quarterly basis, Price to FCF fell 12.98% year-over-year to 14.06 in Q2 2026; TTM through Jun 2026 was 4.23, a 73.02% decrease from a year earlier, with the FY2025 full-year figure at 4.96, down 95.25% from the prior year.
• Price to FCF was 14.06 for Q2 2026 at Pacific Biosciences Of California, down from 8.59 in the prior quarter.
• The five-year high for Price to FCF was 6.7 in Q2 2024, with the low at 75.7 in Q2 2023.
• Average Price to FCF over 5 years is 22.69, with a median of 18.1 recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Price to FCF surged 96.18% in 2022, then slumped 392.1% in 2023.
• Over 5 years, Price to FCF stood at 28.3 in 2022, then sank by 55.77% to 44.08 in 2023, then surged by 62.12% to 16.7 in 2024, then plunged by 69.68% to 28.33 in 2025, then surged by 50.37% to 14.06 in 2026.
• The last three Price to FCF figures came in at 14.06 (Q2 2026), 8.59 (Q1 2026), and 28.33 (Q4 2025), per Business Quant data.